Top

Published in:

01-05-2011 | Original Paper

Substance Use and the Quality of Patient-Provider Communication in HIV Clinics

Authors: P. Todd Korthuis, Somnath Saha, Geetanjali Chander, Dennis McCarty, Richard D. Moore, Jonathan A. Cohn, Victoria L. Sharp, Mary Catherine Beach

Published in: AIDS and Behavior | Issue 4/2011

Abstract

The objective of this study was to estimate the influence of substance use on the quality of patient-provider communication during HIV clinic encounters. Patients were surveyed about unhealthy alcohol and illicit drug use and rated provider communication quality. Audio-recorded encounters were coded for specific communication behaviors. Patients with vs. without unhealthy alcohol use rated the quality of their provider’s communication lower; illicit drug user ratings were comparable to non-users. Visit length was shorter, with fewer activating/engaging and psychosocial counseling statements for those with vs. without unhealthy alcohol use. Providers and patients exhibited favorable communication behaviors in encounters with illicit drug users vs. non-users, demonstrating greater evidence of patient-provider engagement. The quality of patient-provider communication was worse for HIV-infected patients with unhealthy alcohol use but similar or better for illicit drug users compared with non-users. Interventions should be developed that encourage providers to actively engage patients with unhealthy alcohol use.

Bing EG, Burnam MA, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58(8):721–8.PubMedCrossRef

Korthuis PT, Josephs JS, Fleishman JA, et al. Substance abuse treatment in human immunodeficiency virus: the role of patient-provider discussions. J Subst Abuse Treat. 2008;35(3):294–303.PubMedCrossRef

Andersen RM, Bozzette SA, Shapiro MF, et al. Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS consortium. HIV cost and services Utilization Study. Health Serv Res. 2000;35(2):389–416.PubMed

Gebo KA, Fleishman JA, Conviser R, et al. Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001. J Acquir Immune Defic Syndr. 2005;38(1):96–103.PubMedCrossRef

Mathews WC, McCutchan JA, Asch SM, et al. National estimates of HIV-related symptom prevalence from the HIV cost and services utilization study. Med Care. 2000;38(7):750–62.PubMedCrossRef

Fleishman JA, Gebo KA, Reilly ED, et al. Hospital and outpatient health services utilization among HIV-infected adults in care 2000–2002. Med Care. 2005;43(9 Suppl):III40–52.PubMed

Turner BJ, Laine C, Cosler L, Hauck WW. Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users. J Gen Intern Med. 2003;18(4):248–57.PubMedCrossRef

Turner BJ, Laine C, Yang CP, Hauck WW. Effects of long-term, medically supervised, drug-free treatment and methadone maintenance treatment on drug users’ emergency department use and hospitalization. Clin Infect Dis. 2003;37(5):15.CrossRef

Messeri PA, Abramson DM, Aidala AA, Lee F, Lee G. The impact of ancillary HIV services on engagement in medical care in New York City. AIDS Care. 2002;14(1):15–29.CrossRef

10.

Burnam MA, Bing EG, Morton SC, et al. Use of mental health and substance abuse treatment services among adults with HIV in the United States. Arch Gen Psychiatry. 2001;58(8):729–36.PubMedCrossRef

11.

Palepu A, Raj A, Horton NJ, et al. Substance abuse treatment and risk behaviors among HIV-infected persons with alcohol problems. J Subst Abuse Treat. 2005;28(1):3–9.PubMedCrossRef

12.

Palepu A, Tyndall MW, Joy R, et al. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alcohol Depend. 2006;84(2):188–94.PubMedCrossRef

13.

Hall JA, Irish JT, Roter DL, Ehrlich CM, Miller LH. Gender in medical encounters: an analysis of physician and patient communication in a primary care setting. Health Psychol. 1994;13(5):384–92.PubMedCrossRef

14.

Beach MC, Saha S, Korthuis PT, et al. Differences in patient-provider communication for Hispanic compared to non-Hispanic White patients in HIV care. J Gen Intern Med. 2010;25(7):682–7.PubMedCrossRef

15.

Beach MC, Saha S, Korthuis PT, et al. Patient-provider communication differs for Black compared to White HIV-infected patients. Aids Behav. 2010 (E-published ahead of print).

16.

Johnson RL, Roter D, Powe NR, Cooper LA. Patient race/ethnicity and quality of patient-physician communication during medical visits. Am J Public Health. 2004;94(12):2084–90.PubMedCrossRef

17.

Hall JA, Roter DL, Milburn MA, Daltroy LH. Patients’ health as a predictor of physician and patient behavior in medical visits. A synthesis of four studies. Med Care. 1996;34(12):1205–18.PubMedCrossRef

18.

Roter DL. The outpatient medical encounter and elderly patients. Clin Geriatr Med. 2000;16(1):95–107.PubMedCrossRef

19.

Epstein AM, Taylor WC, Seage GR III. Effects of patients’ socioeconomic status and physicians’ training and practice on patient-doctor communication. Am J Med. 1985;78(1):101–6.PubMedCrossRef

20.

O’Connor PG, Samet JH. Substance abuse: the expanding role of general internal medicine. J Gen Intern Med. 2002;17(5):398–9.PubMed

21.

Friedmann PD, Lemon SC, Stein MD, Etheridge RM, D’Aunno TA. Linkage to medical services in the drug abuse treatment outcome study. Med Care. 2001;39(3):284–95.PubMedCrossRef

22.

Friedmann PD, Saitz R, Samet JH. Management of adults recovering from alcohol or other drug problems: relapse prevention in primary care. JAMA. 1998;279(15):1227–31.PubMedCrossRef

23.

Yamada T, Chen C-C, Yamada T. Economic evaluation of relapse prevention for substance users: treatment settings and health care policy. Adv Health Econ Health Serv Res. 2005;16:431–50.PubMedCrossRef

24.

Bakken S, Holzemer WL, Brown MA, et al. Relationships between perception of engagement with health care provider and demographic characteristics, health status, and adherence to therapeutic regimen in persons with HIV/AIDS. Aids Patient Care STDS. 2000;14(4):189–97.PubMedCrossRef

25.

Schneider J, Kaplan SH, Greenfield S, Li W, Wilson IB. Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. J Gen Intern Med. 2004;19(11):1096–103.PubMedCrossRef

26.

Beach MC, Keruly J, Moore RD. Is the quality of the patient-provider relationship associated with better adherence and health outcomes for patients with HIV? J Gen Intern Med. 2006;21(6):661–5.PubMedCrossRef

27.

Gebo KA, Moore RD, Fleishman JA. The HIV research network: a unique opportunity for real time clinical utilization analysis in HIV. Hopkins HIV Rep. 2003;15(6):5–6.PubMed

28.

Cacciola JS, Alterman AI, McLellan A, Lin Y-T, Lynch KG. Initial evidence for the reliability and validity of a “Lite” version of the addiction severity index. Drug Alcohol Depend. 2007;87(2–3):297–302.PubMedCrossRef

29.

Kosten TR, Rounsaville BJ, Kleber HD. Concurrent validity of the addiction severity index. J Nerv Ment Dis. 1983;171(10):606–10.PubMedCrossRef

30.

McLellan AT, Luborsky L, Cacciola J, et al. New data from the addiction severity index. Reliability and validity in three centers. J Nerv Ment Dis. 1985;173(7):412–23.PubMedCrossRef

31.

Stoffelmayr BE, Mavis BE, Kasim RM. The longitudinal stability of the addiction severity index. J Subst Abuse Treat. 1994;11(4):373–8.PubMedCrossRef

32.

Hodgins DC, el-Guebaly N. More data on the addiction severity index. Reliability and validity with the mentally ill substance abuser. J Nerv Ment Dis. 1992;180(3):197–201.PubMedCrossRef

33.

Joyner LM, Wright JD, Devine JA. Reliability and validity of the addiction severity index among homeless substance misusers. Subst Use Misuse. 1996;31(6):729–51.PubMedCrossRef

34.

Brown LS Jr, Alterman AI, Rutherford MJ, Cacciola JS, Zaballero AR. Addiction severity index scores of four racial/ethnic and gender groups of methadone maintenance patients. J Subst Abuse. 1993;5(3):269–79.PubMedCrossRef

35.

Roter D. Roter interaction analysis manual. Baltimore, MD: Johns Hopkins University Bloomberg School of Public Health; 1999.

36.

Roter D, Larson S. The roter interaction analysis system (RIAS): utility and flexibility for analysis of medical interactions. Patient Educ Couns. 2002;46(4):243–51. (see comment).PubMedCrossRef

37.

Roter DL, Hall JA, Katz NR. Relations between physicians’ behaviors and analogue patients’ satisfaction, recall, and impressions. Med Care. 1987;25(5):437–51.PubMedCrossRef

38.

Stewart AL, Napoles-Springer A, Perez-Stable EJ. Interpersonal processes of care in diverse populations. Milbank Q. 1999;77(3):305–39.PubMedCrossRef

39.

Wilson IB, Ding L, Hays RD, et al. HIV patients’ experiences with inpatient and outpatient care: results of a national survey. Med Care. 2002;40(12):1149–60.PubMedCrossRef

40.

Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med. 1994;10(2):77–84.PubMed

41.

Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401.CrossRef

42.

Phin J. Nonpatient polydrug users. In: Wesson D, Carlin A, Adams K, Beschner G, editors. Polydrug abuse: the results of a national collaborative study. New York, NY: Academic Press; 1978. p. 31–57.

43.

Turner BJ, Fleishman JA, Wenger N, et al. Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons. J Gen Intern Med. 2001;16(9):625–33.PubMedCrossRef

44.

White-Means S, Zhiyong D, Hufstader M, Brown LT. Cultural competency, race, and skin tone bias among pharmacy, nursing, and medical students: implications for addressing health disparities. Med Care Res Rev. 2009;66(4):436–55.PubMedCrossRef

45.

Schwartz MB, Chambliss HON, Brownell KD, Blair SN, Billington C. Weight bias among health professionals specializing in obesity. Obes Res. 2003;11(9):1033–9.PubMedCrossRef

46.

Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the patient activation measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res. 2004;39(4 Pt 1):1005–26.PubMedCrossRef

47.

Hibbard JH, Mahoney ER, Stock R, Tusler M. Do increases in patient activation result in improved self-management behaviors? Health Serv Res. 2007;42(4):1443–63.PubMedCrossRef

48.

Kaplan SH, Greenfield S, Ware JE Jr. Assessing the effects of physician-patient interactions on the outcomes of chronic disease. Med Care. 1989;27(3 Suppl):S110–27. (erratum appears in Med Care 1989;27(7):679).PubMedCrossRef

49.

Pringle M, Stewart-Evans C. Does awareness of being video recorded affect doctors’ consultation behaviour? Br J Gen Pract. 1990;40(340):455–8.PubMed

50.

Wolraich ML, Albanese M, Stone G, et al. Medical communication behavior system. An interactional analysis system for medical interactions. Med Care. 1986;24(10):891–903.PubMedCrossRef

51.

McLellan AT, Luborsky L, Woody GE, O’Brien CP. An improved diagnostic evaluation instrument for substance abuse patients. The addiction severity index. J Nerv Ment Dis. 1980;168(1):26–33.PubMedCrossRef

Title: Substance Use and the Quality of Patient-Provider Communication in HIV Clinics
Authors: P. Todd Korthuis
Somnath Saha
Geetanjali Chander
Dennis McCarty
Richard D. Moore
Jonathan A. Cohn
Victoria L. Sharp
Mary Catherine Beach
Publication date: 01-05-2011
Publisher: Springer US
Published in: AIDS and Behavior / Issue 4/2011
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-010-9779-8

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Substance Use and the Quality of Patient-Provider Communication in HIV Clinics

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2011

Factors Associated with Refusal of Rapid HIV Testing in an Emergency Department

Factors Associated with HIV Testing History and Returning for HIV Test Results Among Men Who have Sex with Men in Thailand

Number of Sexual Partners and Associations with Initiation and Intensity of Substance Use

Patient and Provider-Reported Symptoms in the Post-cART Era

Discussion of Sexual Risk Behavior in HIV Care is Infrequent and Appears Ineffectual: A Mixed Methods Study

The Association of HIV Counseling and Testing with HIV Risk Behaviors in a Random Population-based Survey in Kisumu, Kenya

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page